AKT1 and non-small cell lung carcinoma: For example, in NSCLC cells, significantly increased rates of AKT/mTOR signaling pathway activation led to the inhibition of autophagy in cancer cells and the promotion of tumor progression (Wang et al., 2016), suggesting the AKT/mTOR signaling axis as a potential therapeutic target for tumors.